Research Article

Molecular interactions between circadian gene TIMELESS and BCG immunization

Volume: 34 Number: 2 December 26, 2025
EN

Molecular interactions between circadian gene TIMELESS and BCG immunization

Abstract

Tuberculosis (TB) remains a major global health issue, causing 1.3 million deaths each year. Although BCG vaccination coverage is high, its effectiveness in preventing adult TB is limited, especially with the rise of drug-resistant strains. Circadian rhythms, regulated by clock proteins such as TIMELESS, influence immune responses and other biological functions. This study explores TIMELESS's role in shaping immune responses to BCG stimulation and considers whether aligning vaccination with circadian cycles might improve efficacy HEK293T cells were genetically edited using CRISPR/Cas9 to knock out the TIMELESS gene. These cells were then stimulated with BCG, and gene expression was assessed using the RT² Profiler™ PCR Array (Human Innate & Adaptive Immune Responses). Additionally, in silico tools were used to analyze TIMELESS's evolutionary relationships, structural features, and miRNA interactions.BCG stimulation led to a 90% increase in immune gene expression. Most immune genes were downregulated in TIMELESS knockout cells without BCG, except CD8A, which increased 1.97-fold. When knockout cells were stimulated with BCG, CD40, CD40LG, and SLC11A1 increased expression, indicating enhanced T-cell and macrophage activation. These findings suggest that TIMELESS is crucial for proper immune function during BCG stimulation. Its absence alters key immune pathways, particularly CD40-CD40LG and SLC11A1-related responses. Understanding TIMELESS's role may support the development of circadian-based vaccine strategies to improve TB control and vaccine effectiveness.

Keywords

Supporting Institution

Hacettepe University Scientific Research Projects Management Coordinatorship Unit

Project Number

TYL-2022-20000

References

  1. Zumla, A.I., Gillespie, S.H., Hoelscher, M., Philips, P.P., Cole, S.T., Abubakar, I., McHugh, T.D., Schito, M., Maeurer, M., Nunn, A.J., New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infections Diseases, 14 (2014), 327–340. https://doi.org/10.1016/S1473-3099(13)70328-1
  2. Goletti, D., Meintjes, G., Andrade, B.B., Zumla, A., Shan Lee, S., Insights from the 2024 WHO Global Tuberculosis Report – More comprehensive action, innovation, and investments required for achieving WHO End TB goals. International Journal of Infections Diseases, 150 (2025), 107325. https://doi.org/10.1016/j.ijid.2024.107325
  3. Soto, J.A., Gálvez, N.M.S., Andrade, C.A., Ramírez, M.A., Riedel, C.A., Kalergis, A.M., Bueno, S.M., BCG vaccination induces cross-protective immunity against pathogenic microorganisms. Trends in Immunology, 43 (2022), 322–335. https://doi.org/10.1016/j.it.2021.12.006
  4. Dow, C.T., Kidess, L., BCG Vaccine – The Road Not Taken. Microorganisms, 10 (2022), 1919. https://doi.org/10.3390/microorganisms10101919
  5. Liu, X., Li, H.R., Li, S.S., Yuan, J.F., Pang, Y., Maintenance and recall of memory T cell populations against tuberculosis: implications for vaccine design. Front Immunology, 14 (2023), 1100741. https://doi.org/10.3389/fimmu.2023.1100741
  6. Bettencourt, P.J.G., Joosten, S.A., Arlehamn, C.S.L., Behr, M.A., Locht, C., Neyrolles, O., 100 years of the Bacillus Calmette–Guérin vaccine. Vaccine, 39 (2021), 7221–7222. https://doi.org/10.1016/j.vaccine.2021.11.038
  7. Covián, C., Fernández-Fierro, A., Retamal-Díaz, A., Díaz, F.E., Vasquez, A.E., Lay, M.K., Riedel, C.A., González, P.A., Bueno, S.M., Kalergis, A.M., BCG-induced cross-protection and development of trained immunity: implications for vaccine design. Front Immunology, 10 (2019), 2806. https://doi.org/10.3389/fimmu.2019.02806
  8. DiNardo, A.R., Netea, M.G., Musher, D.M., Postinfectious epigenetic immune modifications a double-edged sword. New England Journal of Medicine, 384 (2021), 261–270. https://doi.org/10.1056/NEJMra2028358

Details

Primary Language

English

Subjects

Structural Biology

Journal Section

Research Article

Publication Date

December 26, 2025

Submission Date

April 26, 2025

Acceptance Date

August 29, 2025

Published in Issue

Year 1970 Volume: 34 Number: 2

Communications Faculty of Sciences University of Ankara Series C Biology licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License